The titration schedule typically looks like this: Weeks 1-4: 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Weeks 13-16: 1.7 mg weekly Week 17 onward: 2.4 mg weekly (maintenance) This gradual approach helps minimize gastrointestinal side effects, which are the most common complaint during the first few weeks
Patients should be advised not to adjust their antihypertensive medicines independently and to report any new symptoms including dizziness, light-headedness, or palpitations to their prescribing clinician promptly
Semaglutide and testosterone work through different biological pathways and do not have significant pharmacokinetic interactions
What the Evidence Actually Shows Being transparent about the evidence tier matters here more than for almost any other peptide, because the hype has outrun the approval timeline
Sakharova, et al (2008) Role of Growth Hormone in Regulating Lipolysis, Proteolysis, and Hepatic Glucose Production during Fasting